Methadone Dispenser – DDS is an IT-based documentation and dispensing system specifically developed for the treatment of opioid dependency, manufactured in Switzerland. It has been designed for Opioid Treatment Programs in clinics, prisons, pharmacies and rehab centers using liquid methadone, methadone tablets, Buprenorphine or Buprenorphine / Naloxone. DDS mainly focuses on three essential requirements: Safety, Efficiency and Transparency

Orexo to explore strategic alternatives for commercialization in the USA

Filed under: buprenorphine naloxone

Based on the recent submission of a New Drug Application for Zubsolv (OX219; a novel combination of buprenorphine and naloxone) to the US Food and Drug Administration and the transfer of Abstral, the novel, rapidly-disintegrating, sublingual …
Read more on The Pharma Letter

Related Buprenorphine Naloxone Information…

Comments are closed.